CROWN LABORATORIES GLOBAL LTD.

Company Registration Number:
NI046592 (Northern Ireland)

Unaudited abridged accounts for the year ended 31 December 2023

Period of accounts

Start date: 01 January 2023

End date: 31 December 2023

CROWN LABORATORIES GLOBAL LTD.

Contents of the Financial Statements

for the Period Ended 31 December 2023

Balance sheet
Notes

CROWN LABORATORIES GLOBAL LTD.

Balance sheet

As at 31 December 2023


Notes

2023

2022


£

£
Fixed assets
Tangible assets: 3 0 15,656
Total fixed assets: 0 15,656
Current assets
Stocks: 621,006 2,544,874
Debtors: 4 122,251 344,294
Cash at bank and in hand: 532,864 358,827
Investments: 5 760,721 0
Total current assets: 2,036,842 3,247,995
Creditors: amounts falling due within one year: 6 (17,289,792) (17,896,541)
Net current assets (liabilities): (15,252,950) (14,648,546)
Total assets less current liabilities: (15,252,950) (14,632,890)
Total net assets (liabilities): (15,252,950) (14,632,890)
Capital and reserves
Called up share capital: 379,817 379,817
Share premium account: 1,754,179 1,754,179
Other reserves: 5,069,249 5,069,249
Profit and loss account: (22,456,195) (21,836,135)
Shareholders funds: (15,252,950) (14,632,890)

The notes form part of these financial statements

CROWN LABORATORIES GLOBAL LTD.

Balance sheet statements

For the year ending 31 December 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 04 November 2024
and signed on behalf of the board by:

Name: J Bedard
Status: Director

The notes form part of these financial statements

CROWN LABORATORIES GLOBAL LTD.

Notes to the Financial Statements

for the Period Ended 31 December 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

CROWN LABORATORIES GLOBAL LTD.

Notes to the Financial Statements

for the Period Ended 31 December 2023

2. Employees

2023 2022
Average number of employees during the period 28 30

CROWN LABORATORIES GLOBAL LTD.

Notes to the Financial Statements

for the Period Ended 31 December 2023

3. Tangible Assets

Total
Cost £
At 01 January 2023 117,421
At 31 December 2023 117,421
Depreciation
At 01 January 2023 101,765
Charge for year 15,656
At 31 December 2023 117,421
Net book value
At 31 December 2023 0
At 31 December 2022 15,656

CROWN LABORATORIES GLOBAL LTD.

Notes to the Financial Statements

for the Period Ended 31 December 2023

4. Debtors

2023 2022
££
Debtors due after more than one year: 122,251 344,294

Trade Debtors: 2023- £164,970 / 2022- £294,062 / VAT and GST/HST Receivable: 2023- -£144,064 / 2022- -£58,984 / Other Debtors: 2023- £101,345 / 2022- £109,216

CROWN LABORATORIES GLOBAL LTD.

Notes to the Financial Statements

for the Period Ended 31 December 2023

5. Current investments

Assets Held for Sale £760,721

CROWN LABORATORIES GLOBAL LTD.

Notes to the Financial Statements

for the Period Ended 31 December 2023

6. Creditors: amounts falling due within one year note

Trade Creditors: 2023- £204,915 / 2022- £544,734 / Taxation and Social Security Costs: 2023- £141,830 / 2022- £185,900 / Other Creditors: 2023- £16,505,543 / 2022- £17,093,170 / Accruals: 2023- £437,504 / 2022- £72,737

CROWN LABORATORIES GLOBAL LTD.

Notes to the Financial Statements

for the Period Ended 31 December 2023

7. Related party transactions

Name of the related party:
Relationship:
Related Company
Description of the Transaction: The related company incurred expenses paid on behalf of Crown Laboratories Global.
£
Balance at 01 January 2023 1,108,698
Balance at 31 December 2023 1,049,065